Skip to main content
. 2017 Mar 30;8(18):30606–30616. doi: 10.18632/oncotarget.16725

Figure 1. Putative relations among metabolic syndrome, endocrine disruptors, growth factors, inflammation, lipid/protein chemical modifications and prostate cancer biology.

Figure 1